Isocitrate dehydrogenase (IDH) inhibitor, AG-120 racemic, Purity ≥98%

Cat. No.: X24-09-YM321

Isocitrate dehydrogenase (IDH) inhibitor, AG-120 racemic, Purity ≥98%

Synonym: 1448346-63-1; AG120; AG 120; Ivosidenib; (2S)-N-[1-(2-Chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; Isocitrate dehydrogenase (IDH) inhibitor

  • MDL: MFCD29044889
  • CAS Number: 1448346-63-1
  • Compound CID: 89699486
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
AG-120 racemic, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting isocitrate dehydrogenase (IDH). The molecular weight of the compound is 582.97, and its molecular formula is C28H22ClF3N6O3.
Molecular Weight
582.97
Molecular Formula
C28H22ClF3N6O3
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 95 mg/mL (162.95 mM); Water: insoluble; Ethanol: 95 mg/mL (162.95 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
AG-120 racemic can be studied extensively for its potential therapeutic applications in the treatment of acute myeloid leukemia (AML) and other IDH1-mutant cancers.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0